0001209191-18-038316.txt : 20180618
0001209191-18-038316.hdr.sgml : 20180618
20180618162936
ACCESSION NUMBER: 0001209191-18-038316
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180618
DATE AS OF CHANGE: 20180618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRYGOCKI MARK A SR
CENTRAL INDEX KEY: 0001257544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 18904983
MAIL ADDRESS:
STREET 1: C/O MEDICS
STREET 2: 8125 N. HAYDEN RD
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 GARRETT STREET
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 434-980-8100
MAIL ADDRESS:
STREET 1: 200 GARRETT STREET
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-14
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001257544
PRYGOCKI MARK A SR
C/O VERRICA PHARMACEUTICALS INC.
10 NORTH HIGH STREET, SUITE 200
WEST CHESTER
PA
19380
1
0
0
0
Stock Option (Right to Buy)
15.00
2018-06-14
4
A
0
17502
0.00
A
2028-06-14
Common Stock
17502
17502
D
1/3 of the total shares subject to the option shall vest on June 14, 2019 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.
/s/ Edward Sniezek, Attorney-in-Fact
2018-06-18